DASI Simulations earns FDA clearance for second AI-powered imaging product; continues to build structural heart platform
DASI Dimensions offers AI-powered, accurate, efficient pre-procedural measurement for heart valve replacement
DUBLIN, OH, UNITED STATES, September 10, 2024 /EINPresswire.com/ — DASI Simulations announced today that its second product – DASI Dimensions – has earned FDA clearance. “Our mission – to provide an artificial intelligence (AI)-powered structural heart platform that allows physicians to be more efficient and use their expertise more effectively – is moving forward with great momentum,” said Teri Sirset, founder and CEO.
